Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

377 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
3D-printed simulator for nasopharyngeal swab collection for COVID-19.
Koch A, Vermel M, Hansmann Y, Lodi M, Mura C, Sananes A, Gallien S, Wurtz É, Bleibtreu A, Martinot M, Exinger J, Lescure X, Kerneis S, Lacombe K, Mootien JY, Shawali C, Lecointre L, Debry C, Lefebvre N, Sananes N. Koch A, et al. Among authors: lacombe k. Infect Dis Now. 2022 May;52(3):138-144. doi: 10.1016/j.idnow.2022.02.002. Epub 2022 Feb 8. Infect Dis Now. 2022. PMID: 35149235 Free PMC article.
Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019.
Martinot M, Jary A, Fafi-Kremer S, Leducq V, Delagreverie H, Garnier M, Pacanowski J, Mékinian A, Pirenne F, Tiberghien P, Calvez V, Humbrecht C, Marcelin AG, Lacombe K. Martinot M, et al. Among authors: lacombe k. Clin Infect Dis. 2021 Oct 5;73(7):e1762-e1765. doi: 10.1093/cid/ciaa1474. Clin Infect Dis. 2021. PMID: 32986807 Free PMC article.
Cyber harassment of female scientists will not be the new norm.
Samer C, Lacombe K, Calmy A. Samer C, et al. Among authors: lacombe k. Lancet Infect Dis. 2021 Apr;21(4):457-458. doi: 10.1016/S1473-3099(20)30944-0. Epub 2020 Dec 24. Lancet Infect Dis. 2021. PMID: 33357516 Free PMC article. No abstract available.
Tocilizumab in Coronavirus Disease 2019: Give It Time!
Richier Q, Plaçais L, Lacombe K, Hermine O. Richier Q, et al. Among authors: lacombe k. Clin Infect Dis. 2021 Dec 16;73(12):2368-2369. doi: 10.1093/cid/ciab081. Clin Infect Dis. 2021. PMID: 33515253 Free PMC article. No abstract available.
Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial.
Dubée V, Roy PM, Vielle B, Parot-Schinkel E, Blanchet O, Darsonval A, Lefeuvre C, Abbara C, Boucher S, Devaud E, Robineau O, Rispal P, Guimard T, d'Anglejean E, Diamantis S, Custaud MA, Pellier I, Mercat A; HYCOVID study group; HYCOVID investigators; Angers University Hospital; Cholet Hospital; Laval Hospital; Le Mans Hospital; Tours University Hospital; Quimper Hospital; La Roche sur Yon Hospital; Tourcoing Hospital; Orléans Hospital; Nantes University Hospital; Niort Hospital; Lorient Hospital; Brest University Hospital; Cherbourg Hospital; Saint-Brieuc Hospital; Créteil – APHP University Hospital; Saint-Antoine – APHP University Hospital; Saint-Etienne University Hospital; Toulouse University Hospital; Melun Hospital; Dijon University Hospital; Princesse Grace – Monaco Hospital; Versailles Hospital; Colmar Hospital; Agen-Nerac Hospital; Caen University Hospital; Saint-Nazaire Hospital; Nantes – Confluent Hospital; Limoges University Hospital; Poitiers University Hospital; Amiens University Hospital; Bobigny – APHP University Hospital; Cergy-Pontoise Hospital; Valencienne Hospital; Valencienne – Clinique Tessier Hospital; Henri-Mondor – APHP University Hospital; Chalon-sur-Saône… See abstract for full author list ➔ Dubée V, et al. Clin Microbiol Infect. 2021 Aug;27(8):1124-1130. doi: 10.1016/j.cmi.2021.03.005. Epub 2021 Apr 1. Clin Microbiol Infect. 2021. PMID: 33813110 Free PMC article. Clinical Trial.
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19.
Ader F, Peiffer-Smadja N, Poissy J, Bouscambert-Duchamp M, Belhadi D, Diallo A, Delmas C, Saillard J, Dechanet A, Mercier N, Dupont A, Alfaiate T, Lescure FX, Raffi F, Goehringer F, Kimmoun A, Jaureguiberry S, Reignier J, Nseir S, Danion F, Clere-Jehl R, Bouiller K, Navellou JC, Tolsma V, Cabié A, Dubost C, Courjon J, Leroy S, Mootien J, Gaci R, Mourvillier B, Faure E, Pourcher V, Gallien S, Launay O, Lacombe K, Lanoix JP, Makinson A, Martin-Blondel G, Bouadma L, Botelho-Nevers E, Gagneux-Brunon A, Epaulard O, Piroth L, Wallet F, Richard JC, Reuter J, Staub T, Lina B, Noret M, Andrejak C, Lê MP, Peytavin G, Hites M, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F; DisCoVeRy study group. Ader F, et al. Among authors: lacombe k. Clin Microbiol Infect. 2021 Dec;27(12):1826-1837. doi: 10.1016/j.cmi.2021.05.020. Epub 2021 May 26. Clin Microbiol Infect. 2021. PMID: 34048876 Free PMC article. Clinical Trial.
Tocilizumab and COVID-19: Timing of administration assessment.
Richier Q, Jachiet V, Bonnemains V, Plaçais L, Abisror N, Garnier M, Pacanowski J, Dhote R, Hinchschberger O, Michel M, Bienvenu B, Comarmond C, Lacombe K, Mekinian A. Richier Q, et al. Among authors: lacombe k. Infect Dis Now. 2022 Feb;52(1):31-34. doi: 10.1016/j.idnow.2021.06.304. Epub 2021 Jun 29. Infect Dis Now. 2022. PMID: 34198000 Free PMC article.
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Poissy J, Belhadi D, Diallo A, Lê MP, Peytavin G, Staub T, Greil R, Guedj J, Paiva JA, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F; DisCoVeRy Study Group. Ader F, et al. Lancet Infect Dis. 2022 Feb;22(2):209-221. doi: 10.1016/S1473-3099(21)00485-0. Epub 2021 Sep 14. Lancet Infect Dis. 2022. PMID: 34534511 Free PMC article. Clinical Trial.
Persistent Coronavirus Disease 2019 (COVID-19) in an Immunocompromised Host Treated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific Monoclonal Antibodies.
Bailly B, Péré H, Veyer D, Berceanu A, Daguindau E, Roux P, Hermine O, de Lamballerie X, Bastard P, Lacombe K, Autran B, Angelot Delettre F, Laurent Casanova J, Imbeaud S, Laure Clairet A, Kroemer M, Spehner L, Robillard N, Puech J, Marty-Quinternet S, Lepiller Q, Chirouze C, Bouiller K. Bailly B, et al. Among authors: lacombe k. Clin Infect Dis. 2022 May 3;74(9):1706-1707. doi: 10.1093/cid/ciab868. Clin Infect Dis. 2022. PMID: 34598278 Free PMC article. No abstract available.
377 results